Physician

Michael Johnson, M.D.

According to 2025 Medicare claims, Michael Johnson, M.D. (NPI: 1548203185) practices ophthalmology in the Charleston-North Charleston, SC market, with the plurality of this provider's patient population coming from Charleston, SC. This provider's primary affiliated billing organization is CHARLESTON NEUROSCIENCES INSTITUTE (NPI: 1225094600; TIN: 202359956) and primary practice location at 29902-6128.

Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,164 traditional Medicare patients, billed 24,794 HCPCS/CPT codes, and received $3,775,544 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,186 prescription claims across 323 beneficiaries totaling $50,295 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 8 records totaling $14,568. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $566,721 to $3,775,544. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $10,859 to $50,295. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.9M$3.8M2015 Medicare payment: $566,721 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $554,285 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $570,729 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $526,244 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $604,692 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $855,949 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,774,493 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,151,443 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,983,777 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,775,544 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,95012,224$566,721
20161,99611,728$554,285
20171,97412,547$570,729
20182,01511,373$526,244
20191,89711,636$604,692
20201,0846,515$855,949
202179110,888$1,774,493
202294110,725$2,151,443
20231,06313,971$2,983,777
20241,16424,794$3,775,544

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$44K$88K2015 Drug cost: $10,859 (USD; Tot_Drug_Cst)2016 Drug cost: $10,478 (USD; Tot_Drug_Cst)2017 Drug cost: $12,527 (USD; Tot_Drug_Cst)2018 Drug cost: $28,601 (USD; Tot_Drug_Cst)2019 Drug cost: $86,487 (USD; Tot_Drug_Cst)2020 Drug cost: $63,811 (USD; Tot_Drug_Cst)2021 Drug cost: $54,094 (USD; Tot_Drug_Cst)2022 Drug cost: $69,995 (USD; Tot_Drug_Cst)2023 Drug cost: $87,733 (USD; Tot_Drug_Cst)2024 Drug cost: $50,295 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201585242$10,859
201664186$10,478
201769181$12,527
2018109241$28,601
2019183615$86,487
2020142439$63,811
2021180667$54,094
2022217965$69,995
20232761,267$87,733
20243231,186$50,295

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3682,013$94
92014Established patient complete exam of visual system630770$82
92012Established patient problem focused exam of visual system425618$68
92134Imaging of retina9982,522$29
92250Photography of the retina549829$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1294,879$6,676
Alphagan PBrimonidine Tartrate18549$4,874
Brimonidine TartrateBrimonidine Tartrate27014,340$4,574
LatanoprostLatanoprost35423,351$3,499
AcetazolamideAcetazolamide251,003$2,710

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.7$268Regeneron Healthcare Solutions, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.1$14,300EyePoint Pharmaceuticals US, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael Johnson, M.D.?

Tedicare shows public-source Medicare data for Michael Johnson, M.D. (NPI 1548203185), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael Johnson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Michael Johnson, M.D.?

Michael Johnson, M.D. is linked to CHARLESTON NEUROSCIENCES INSTITUTE (billing NPI 1225094600) in the available physician profile data.

Does Michael Johnson, M.D. have Open Payments data?

Michael Johnson, M.D. has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.